| Literature DB >> 32735095 |
Sang Ik Oh1,2, Jong Wan Kim1, Jongho Kim1, Byungjae So1, Bumseok Kim2, Ha Young Kim3.
Abstract
BACKGROUND: Streptococcus dysgalactiae subspecies equisimilis (SDSE) acts as an etiological agent for lameness, neurological signs, and high mortality in pigs. Despite its importance in pig industries and zoonotic potential, little is known about the effects of this pathogen.Entities:
Keywords: Drug resistance; Streptococcus dysgalactiae subspecies equisimilis; multilocus sequence typing; swine; virulence
Mesh:
Substances:
Year: 2020 PMID: 32735095 PMCID: PMC7402932 DOI: 10.4142/jvs.2020.21.e57
Source DB: PubMed Journal: J Vet Sci ISSN: 1229-845X Impact factor: 1.672
Clinical features of the swine cases in this study
| Case No. | Age (day) | Year of case submission | Source of SDSE isolation | Other pathogens detected (sample) | Clinical signs of cases | ||||
|---|---|---|---|---|---|---|---|---|---|
| LM | NS | SD | MM | RS | |||||
| 1 | 3 | 2016 | Peritoneal cavity | ND | + | + | |||
| 2 | 5 | 2015 | Joint | ND | + | + | |||
| 3 | 10 | 2013 | Joint | ND | + | + | |||
| 4 | 10 | 2015 | Lung | ND | + | ||||
| 5 | 20 | 2010 | Lung | PM, SSUIS, PCV2 (lung) | + | + | |||
| 6 | 40 | 2017 | Joint | PM, HPS, MHR (lung) | + | ||||
| 7 | 45 | 2008 | Lung | PM, PRRSV, PCV2 (lung) | + | ||||
| 8 | 45 | 2014 | Joint | ND | + | + | + | ||
| 9 | 50 | 2008 | Lung | PM (lung) | + | + | + | ||
| 10 | 60 | 2010 | Lung | HPS, MHR (lung) | + | + | + | ||
| 11 | 70 | 2013 | Pericardium | PM (nasal concha) | + | ||||
SDSE, Streptococcus dysgalactiae subspecies equisimilis; ND, not detected; HPS, Haemophilus parasuis; MHR, Mycoplasma hyorhinis; PCV2, porcine circovirus type 2; PM, Pasteurella multocida; PRRSV, porcine reproductive and respiratory syndrome virus; SSUIS, Streptococcus suis; LM, lameness; NS, neurological sign; SD, sudden death; MM, mass mortality; RS, respiratory symptom.
Phenotypic and genotypic characteristics of SDSE isolates from clinically diseased pigs
| Case No. | Lancefield group | Similarity to 16S rRNA sequence of SDSE type strain (%) | GenBank accession No. | Virulence gene profile | |||||
|---|---|---|---|---|---|---|---|---|---|
| SAg genes* | |||||||||
| 1 | C | 97.5 | KY986697 | + | + | + | - | - | - |
| 2 | C | 99.9 | KY986688 | + | + | + | - | - | - |
| 3 | C | 99.9 | KY986687 | + | + | - | - | - | - |
| 4 | C | 99.3 | KY986693 | + | + | + | - | - | - |
| 5 | C | 99.9 | KY986694 | + | + | - | - | - | - |
| 6 | C | 98.5 | KY986696 | + | + | - | - | - | - |
| 7 | C | 95.0 | KY986689 | + | + | - | - | - | - |
| 8 | C | 93.5 | KY986695 | + | + | - | - | - | - |
| 9 | C | 97.0 | KY986690 | + | + | + | - | - | - |
| 10 | C | 98.6 | KY986691 | + | + | + | - | - | - |
| 11 | C | 100 | KY986692 | + | + | - | - | - | - |
SDSE, Streptococcus dysgalactiae subspecies equisimilis; rRNA, ribosomal RNA; SAg, superantigenic.
*SAg genes: speA, speC, speG, speH, speI, speJ, speK, speL, speM, ssa, smez, and speG.
Molecular epidemiological characteristics of SDSE isolates from clinically diseased pigs
| Case No. | MLST scheme | |||
|---|---|---|---|---|
| Allelic profile* | ST | CC | ||
| 1 | 30-13-6-30-12-13-33 | Singleton | ||
| 2 | NT | 30-13-6-6-12-56-33 | 252 | 252/339 |
| 3 | NT | 32-13-28-30-39-48-29 | 315 | 315/336 |
| 4 | NT | 30-13-6- | 252/339 | |
| 5 | NT | 32-13-28-28-39-48-29 | 315/336 | |
| 6 | NT | 30-13-6-27-39- | Singleton | |
| 7 | NT | 32-13-28-30-39-48-29 | 315 | 315/336 |
| 8 | NT | 32-13-6-27-39-48-33 | Singleton | |
| 9 | NT | 32-33-27-27-39-48-29 | 234 | Singleton |
| 10 | NT | 30-13-6-6-12-56-33 | 252 | 252/339 |
| 11 | NT | 32-13-28-30-39-48-29 | 315 | 315/336 |
SDSE, Streptococcus dysgalactiae subspecies equisimilis; MLST, multilocus sequence typing; ST, sequence type; CC, clonal complex; NT, non-typable.
*Allelic profile, gki-gtr-murI-mutS-recP-xpt-atoB.
Novel alleles and STs are marked in bold.
Fig. 1Minimum spanning tree based on sequence types of 494 Streptococcus dysgalactiae subspecies equisimilis strains isolated from humans, horses, pigs, and dogs. The size of each circle is proportional to the number of isolates with that particular sequence type on a logarithmic scale. Numbers on branches represent the number of loci that differ from the founder sequence type.
MIC value distribution, MIC50, and MIC90 of SDSE strains from clinical diseased pigs against the tested antimicrobials
| Case No. | MIC (µg/mL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Beta-lactams | Macrolides | Tetracyclines | Fluoroquinolones | |||||||
| TIO | PEN | AMP | TYL | TIL | TUL | CTE | OTE | DAN | ENR | |
| 1 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | 2 |
| 2 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | 1 |
| 3 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | 1 |
| 4 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | 2 |
| 5 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | ≤ 0.5 | ≤ 4 | 16 | > 8 | > 8 | > 1 | 2 |
| 6 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | > 2 |
| 7 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | ≤ 0.5 | ≤ 4 | 32 | > 8 | > 8 | > 1 | 2 |
| 8 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | ≤ 0.5 | ≤ 4 | 16 | > 8 | > 8 | > 1 | 2 |
| 9 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | 32 | 64 | > 8 | > 8 | > 1 | 2 |
| 10 | 0.5 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | 1 |
| 11 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | ≤ 0.5 | ≤ 4 | 16 | > 8 | > 8 | > 1 | 2 |
| MIC50 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | 2 |
| MIC90 | ≤ 0.25 | ≤ 0.12 | ≤ 0.25 | > 32 | > 64 | > 64 | > 8 | > 8 | > 1 | 2 |
SDSE, Streptococcus dysgalactiae subspecies equisimilis; MIC, minimum inhibitory concentration; TIO, ceftiofur; PEN, penicillin; AMP, ampicillin; TYL, tylosin; TIL, tilmicosin; TUL, tulathromycin; CTE, chlortetracycline; OTE, oxytetracycline; DAN, danofloxacin; ENR, enrofloxacin.
Distribution of antimicrobial resistance genes and gyrA, gyrB mutation of SDSE isolates from clinically diseased pigs
| Case No. | Antimicrobial resistance gene | Amino acid substitution in | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Macrolides | Tetracyclines | Fluoroquinolones* | |||||||
| parC | |||||||||
| 1 | - | + | - | - | - | - | + | - | - |
| 2 | - | - | - | - | - | + | + | - | Glu96 to Asp |
| 3 | - | - | - | - | - | - | + | - | - |
| 4 | - | - | - | - | - | - | + | - | - |
| 5 | - | - | - | - | - | - | + | - | - |
| 6 | - | + | - | - | - | - | - | - | Ser79 to Phe |
| 7 | - | - | - | - | - | - | + | - | - |
| 8 | - | - | - | - | - | - | + | - | - |
| 9 | - | - | + | - | - | - | + | - | - |
| 10 | - | - | - | - | - | + | + | - | - |
| 11 | - | - | - | - | - | - | + | - | - |
SDSE, Streptococcus dysgalactiae subspecies equisimilis.
*Amino acid substitution in parC of SDSE isolates resistant to fluoroquinolone compared to the reference SDSE AC-2713 (GenBank accession number: HE85852).